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Abstract 
 
Trigonella foenum-graecum (TFG) is one of medicinal plants containing several steroidal sapogenins, 
such as diosgenin, yamogenin, gitogenin, tigogenin and trigoneoside, and also alkaloid trigonellin and some 
flavonoids such as vitexin, isovitexin, orientin, isoorientin, which has many activities, such as antidiabetic, 
estrogenic, and also anticancer. As phytoestrogen, TFG was predicted to have potency as Selective 
Estrogen Receptor Modulators (SERMs) which is used for hormonal-dependent breast cancer treatment. 
This experiment was carried out to investigate interaction of some sapogenin steroids and flavonoids in 
TFG to estrogen receptor alpha (ERα) and its activity to breast cancer cell line as confirmation. In silico 
prediction was carried out to investigate their estrogenic activity by analyzing their binding affinity to ERα 
using AutoDock Vina program. In vitro activity confirmation of TFG extract and its fractions were carried 
out using MTT assay on Erα-positive human breast cancer cell line, MCF-7. Results showed that free 
binding energies of diosgenin and yamogenin were -6.4 kcal/mol, estradiol was -6.0 kcal/mol, and 
tamoxifen was -5.1 kcal/mol. While cytotoxicity assay showed that ethyl acetate fraction gave the lowest 
IC50 of 41.81 ppm, with total steroid content of 20.03 ppm. From these results, we can conclude that 
diosgenin and yamogenin have greater binding affinity to ERα comparing to estradiol and tamoxifen.  In 
vitro assay confirmation showed that ethyl acetate fraction has cytotoxic effect on MCF-7 cells. 
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INTRODUCTION 
 
Fenugreek seed or Foenigraeci semen is 
dried seed from Trigonella foenum-graecum L., 
(TFG), Leguminosae, (WHO, 2007). Empirically, 
TFG seed is used for treating hemorrhoids, asthma, 
ulcers, and muscle pain, and is often used to 
prevent hair loss, and also as skin softener.  Many 
studies revealed its activity as antidiabetic, 
anticancer, and for hypercholesterolemia handling 
(Mills, et al., 2000).  TFG has antiandrogen 
activities, due to its active compounds as beta-
sitosterol, palmitic-acid, and stearic-acid, and also 
has the ability to decrease total cholesterol, LDL, 
VLDL cholesterol, and triglycerides significantly. 
The anti-hyperglycemic and anti-inflammatory 
properties investigated in fenugreek are additional 
benefit.  TFG can induce uterine contraction, so it 
can not be consumed during pregnancy (Hoffman, 
2004). Agustini, et al. (2007) showed that 
ethanolic extract of TFG seed have estrogenic 
effect on ovariectomized and immature female 
Wistar rats.  Phytoestrogen is used as alternative 
for Hormone Replacement Therapy (HRT) to help 
reducing menopause symptoms. It can be used for 
long term therapy until the body can make 
adaptation on the new hormone level (Badziad, 
2003). Phytoestrogens also have potency to handle 
hormonal-depending breast cancer which is known 
as natural Selective Estrogen Receptor Modulators 
(SERMs). 
TFG was predicted to have estrogenic-like 
effect, also because of some sapogenin steroid 
contents, e.g., diosgenin, precursor for sexual 
hormone (Evans, 2002), its isomer Yamogenin 
(Dewick, 1997), gitogenin, tigogenin, and 
trigoneoside (saponin-like estrogen) which have 
effect as phytoestrogen for menopause symptoms 
therapy (Hoffman, 2004) (Fig. 1).  TFG seed 
contains 0.8-2.2 % diosgenin in free base form  
(Wiryowidagdo, 2000). 
TFG also contains 20-30% fatty oil, 
alkaloids (trigonelline, an alkaloid pyridine, 
gentianin, and karpain), flavonoids e.g. vitexin in 
glycoside or ester form, isovitexin, orientin, 
vicenin, quercetin, and luteolin (Hoffman, 2004), 
essential oil, saponine, nicotinamide, choline, 
bitter compound, and mucilage (Evans, 2002). 
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Figure 1. Sapogenin Steroids of Trigonella foenum-graecum L.: diosgenin (A), yamogenin (B), protodioscin 
(C),  and tigogenin (D). 
 
 
This study was carried out to investigate 
interaction from some sapogenin steroids and 
flavonoids in TFG to estrogen receptor alpha 
(ERα) in silico and the cytotoxicity activity of 
fenugreek seed to breast cancer cell line with 
estrogen receptor positive as confirmation. 
 The in silico study was carried out to 
investigate their estrogenic activity by analyzing 
their binding affinity to ERα using AutoDock Vina 
program.  In vitro confirmation activity of TFG 
extract and its fractions were carried out using 
MTT assay on ERα-positive human breast cancer 
cell line, MCF-7. 
 
MATERIALS AND METHODS 
 
Docking Simulation  
Docking simulation was carried out to 
predict interaction of ERα (PDB ID: 2YAT) as 
protein receptor and four steroid sapogenins 
(Diosgenin, Tigogenin, Gitogenin, and 
Protodioscin) of TFG, estradiol, and tamoxifen as 
ligands. Ligands and macromolecules files were 
prepared by MGL Tools 1.5.4 software. Docking 
was carried out to investigate ligands’ estrogenic 
activity by analyzing their binding affinity to ERα 
using AutoDock Vina program. The size of the 
docking grid was 40Å×40Å×40Å, which 
encompassed the entire ERα structure. 
Visualization of the interactions were done using 
PyMol. 
 
Sample Preparation 
TFG seed were obtained from 
Tawangmangu, Central Java, Indonesia.  Seeds 
were dried and ground, then were extracted with 
methanol and ethanol. The methanolic extract was 
fractioned with n-hexane, ethylacetic (EtOAc), and 
n-buthanol.  All the extracts and fractions were 
dried with vacuum rotary evaporator. 
 
Total Steroid Analysis  
This method was conducted bassed on 
Chapagin, et al., 2005. As many as 1 mg dried 
extract/fraction was diluted in 2 mL ethylacetate in 
a tube, then 1 mL reagent A (containing p-
anysaldehyde and ethylacetate (0.5 : 99.5)) and 1 
mL reagent B (containing glacial sulfuric acid and 
ethyl acetate (1:1)) were added. The tube was put 
in 60ºC water bath for 10 minutes until the color 
changed and then cooled in 25ºC water bath for 10 
minutes. Color intensity was measured by 
spectrophotometer UV Vis 423 nm, against ethyl 
acetate solution as blank. Results were compared 
with standard curve of Diosgenin (Sigma). 
 
Cell Culture 
The MCF-7 cells (Human Breast Cancer 
with Estrogen Receptor Positive) were obtained 
from Laboratory for Development of Industrial 
Agro and Biomedical Technology (LAPTIAB-
BPPT) Indonesia. Cells were routinely maintained 
and grown in 75 cm
2 
 flasks at 37ºC,  5%  CO2 in a  
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95% humidified atmosphere. The growth medium 
was prepared as following: RPMI 1640 (Gibco) 
with phenol red and 2 mM glutamine, 100 U/mL 
penicillin, 0.1 mg/mL Streptomycin, 1 mM sodium 
pyruvate, and supplemented with 10% Fetal 
Bovine Serum (FBS) (Gibco) which had been 
heat-inactivated at 56ºC for 30 minutes. Passaging 
of cells was carried out using 4 mL trypsin-EDTA 
exposure at room temperature in 75 cm
2
 flask for 3 
minutes. After that, 10 mL media with 10% FBS 
was used to reduce the action of trypsin on cells. 
After centrifugation, the obtained cells were 
platted.  
 
Cytotoxicity test with MTT assay 
Cells were distributed into 96-well plates 
(10,000 cells/well) in medium RPMI with phenol 
red containing 10% FBS, 100 U/mL penicillin, 0.1 
mg/mL streptomycin, and 1 mM sodium pyruvate, 
then incubated for 24 hours at 37ºC, 5% CO2 in a 
95% humidified atmosphere. After 24 hours, 
medium was changed with samples (extracts and 
phases of TFG) in growth medium in different 
concentration and incubated for another 24 hours 
at 37ºC, 5% CO2 in a 95% humidified atmosphere. 
Assays were done in a wide range of 
concentration, from 10 ppm until 500 ppm, divided 
into six concentrations variation.  
After 24 hours treatment, the cells were 
washed with Phosphate Buffer Saline (PBS). Then 
the 3-(4,5-Dimethylthiazol-2-yl)-2,5 
Diphenyltetrazolium (MTT) solution in medium 
was added, followed by incubation for 4 hours at 
37ºC, 5% CO2 in a 95% humidified atmosphere. 
The crystal of blue formazan will be formed. After 
that, reaction was stopped by adding Sodium 
Dodecyl Sulphate (SDS) into each well.  Leave 
plate in a dark place for  12  hours (overnight). The 
intensity of the color formed was measured by 
ELISA reader at 570 nm.  
 
 
RESULTS AND DISCUSSION 
 
Recent studies suggest that TFG and its 
active compounds may possess anticarcinogenic 
activity. Raju, et al. (2004) showed that diosgenin, 
a steroidal saponin from TFG could inhibit 
azoxymethane-induced aberrant crypt foci 
formation in F344 rats and induce apoptosis in 
HT-29 human colon cancer cells. Referring to 
Agustini, et al. (2007), TFG had estrogenic effect 
on ovariectomized and immature rats. Some 
phytoestrogens are believed to have SERMs 
activity with no action in the uterus but beneficial 
effects in the hypothalamus/pituitary and in the 
bone (Wuttke, et al., 2003).  According to 
Johnston (2005), the study to search the ideal 
profile of a novel SERMs should be done by 
finding a molecule having greater binding affinity 
into ER in comparison with tamoxifen, and also 
having ability to antagonize estrogen-dependent 
growth of breast cancer cells in vitro (preclinical).   
Interaction of TFG active compounds with 
ER was predicted in silico using docking 
simulation method, which was carried out with 
AutoDockVina program. Free binding energy of 
interaction between some steroidal sapogenins 
steroids to ERα is showed in Table 1. 
The docking process was started with protein 
preparation. During docking, series of poses 
(ligand-protein complexes) were generated for 
each molecule. Docking simulations was carried 
out on the Active Binding Sites such as, Ser 381, 
Cys 447, Ser 530.  Table 1 shows the calculated 
free binding energy (ΔGbind) and the residue 
contact of flexible-ligand docking simulation. The 
negative and low value of ΔGbind indicated the 
strong favorable bond between protein and ligand. 
Based on docking simulation result, diosgenin, 
yamogenin, vitexin, and isovitexin could be 
proposed as a potential inhibitor, but a further 
study still need to be conducted. The docking 
visualization can be seen at Fig. 2. 
 
Table 1.  Predicted ligand free binding energy and residue contact in docking simulation 
No. Compounds Predicted ΔG (kcal/mol) Binding site 
1.  Estradiol  -6.0  Arg 548, Arg 515  
2.  Tamoxifen -5.1  Ser 381, Ala 546  
3.  Diosgenin -6.4 Arg  515 
4.  Protodioscin -5.4  Glu 380, Asn 519, Arg 548, Asp 545  
5.  Tigogenin -6.0  -  
6.  Yamogenin -6.4  -  
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Figure 2. The visualization of the interaction in active binding site of ERα with some ligands: (A) 
estradiol, (B) tamoxifen, (C) diosgenin, (D) yamogenin, (E) tigogenin, and (F) protodioscin. 
 
 
 
Total steroids level analyses showed that 
butanolic fraction contains the highest total steroid 
(25.321 ppm) while for IC50 on MCF-7 cells, 
ethylacetic fraction gave the lowest IC50 (58.63 
ppm). Total steroids analyses results and IC50 on 
MCF-7 can be seen on Table 2. While the growth 
percentage of MCF-7 cells treated with TGFare 
shown in Table 3. Total steroidal content in 
buthanolic fraction (25.32 ppm) is nearly the same 
with ethylacetic fraction (20.03 ppm).   
The major steroidal sapogenin from TFG, 
diosgenin, has been investigated in many 
researches for its cytotoxic activity. Moalic, et al. 
(2001) reported that diosgenin inhibited cell 
proliferation in human osteosarcoma 1547 cell line 
by induction of apoptosis and G1 phase cell cycle 
arrest.   
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Table 2.Total steroid level and IC50 of some fraction of TFG on MCF-7 cells 
 
 
TOTAL STEROID LEVEL 
(ppm) 
 
IC50 on MNF-7 
(ppm) 
Ext.MetOH 19.77 186.09 
Fr. EtOAc 20.03 41.81 
Fr. N-Hex 3.86 102.11 
Fr. N-BuOH 25.32 136.25 
 
 
Table 3.  Percentage growth of Trigonella foenum-graecum L on MCF-7 cells 
Concentration 
(ppm) 
%Growth of MCF-7 cells  
MeOH 
extr. 
EtOAc 
Phase 
Hexane 
Phase 
BuOH 
Phase 
Water Phase 
10 110.609 78.722 75.166 107.737 100.889 
20 111.212 78.541 92.706 97.804 107.946 
50 98.674 30.199 82.821 73.131 102.248 
100 46.655 19.470 46.896 32.253 100.052 
250 18.565 17.963 18.987 20.544 92.211 
500 17.058 17.902 18.867 18.819 73.340 
 
 
Yoshihiro, et al. (2001) studied about 
cytotoxic activities on HL-6 human promyelocytic 
leukemia cells and structure-cytotoxic 
relationships of steroidal saponins.  They found 
that the activities of some sapogenin steroids were 
sensitive to the monosaccharides constituting the 
sugar moieties and their sequences, as well as to 
the structures of the aglycons.  They also 
concluded that structure-activity relationships of 
(25R)-Spirost-5-en-3b-ol (Diosgenin) glycoside 
derivatives Diosgenin b -D-glucoside showed no 
cytotoxic activity against HL-60 cells 
(IC50>20ppm). 
 
CONCLUSION 
 
Diosgenin and yamogenin have greater 
binding affinity with ERα compared to estradiol 
and tamoxifen. In vitro assay confirmation showed 
that ethyl acetate fraction have cytotoxic effect on 
MCF-7 cells (IC50 41.81 ppm) and contains 
steroids (20.03 ppm).  
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